{"transactions":[{"id":3371436,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":153813,"kind":"person","name":"Bhadauria Pradeep","position":1,"cik":"0001774812","reported_name":"Bhadauria Pradeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2019-11-14T22:26:49.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":153846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020."}],"balance_after":153846,"derivative":{"exercise_price":2.75,"expiration_date":"2029-04-15","underlying":"Class A Common Stock","underlying_shares":153846},"source":{"system":"sec-edgar","filing":"0001723128-19-000129","document":"wf-form4_157377039293557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000129/wf-form4_157377039293557.xml","form_type":"4"}},{"id":3371435,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":153813,"kind":"person","name":"Bhadauria Pradeep","position":1,"cik":"0001774812","reported_name":"Bhadauria Pradeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2019-11-14T22:26:49.000Z","date":"2019-11-13","kind":"disposition_to_issuer","acquired":false,"shares":153846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020."}],"balance_after":0,"derivative":{"exercise_price":13.28,"expiration_date":"2029-04-15","underlying":"Class A Common Stock","underlying_shares":153846},"source":{"system":"sec-edgar","filing":"0001723128-19-000129","document":"wf-form4_157377039293557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000129/wf-form4_157377039293557.xml","form_type":"4"}},{"id":3434630,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":153813,"kind":"person","name":"Bhadauria Pradeep","position":1,"cik":"0001774812","reported_name":"Bhadauria Pradeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2019-08-20T01:03:08.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":30000,"price":2.41,"value":72300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were acquired in multiple transactions at prices ranging from $2.40 per share to $2.43 per share.  The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001723128-19-000118","document":"wf-form4_156626296989842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000118/wf-form4_156626296989842.xml","form_type":"4"}},{"id":3524006,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":153813,"kind":"person","name":"Bhadauria Pradeep","position":1,"cik":"0001774812","reported_name":"Bhadauria Pradeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2019-05-16T20:59:54.000Z","date":"2019-05-15","kind":"purchase","acquired":true,"shares":7000,"price":8.48,"value":59360.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were acquired in multiple transactions at prices ranging from $8.30 per share to $8.55 per share.  The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001723128-19-000097","document":"wf-form4_155804037951157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000097/wf-form4_155804037951157.xml","form_type":"4"}}]}